Apr 17, 2024

‘Smart people’ working to make a difference: Co-op student reflects on OICR conference

Apr 02, 2024

FDA approves first cell therapy in landmark achievement for personalized medicine

Dec 02, 2020

Study uncovers new approach to mobilize the immune system against hard-to-treat breast cancers

Jul 08, 2020

Protecting cancer patients from COVID-19: world-first clinical trial tests a novel immune-boosting strategy

Nov 18, 2019

Potential new approach to T-cell therapy shows early promise in the lab

Oct 04, 2019

Meet our new Lebovic Fellows

Jul 03, 2019

Bridges built between Israel and Canada thanks to philanthropic donation from Joseph and Wolf Lebovic

May 21, 2019

Activating the immune system to fight cancer

Nov 08, 2018

Gene signature discovery may predict response to immune therapy

Nov 06, 2018

Discovering new ways to deploy the immune system against hidden cancers

Aug 16, 2018

Researchers find common cell process key to therapy resistance

Jul 27, 2018

BioLab helps scientists get the most out of Ontario’s cancer research infrastructure

Jun 14, 2018

New OICR President and Scientific Director comments on breakthrough in breast cancer T-cell immunotherapy

Jun 13, 2018

Viral protein identified as one of the main drivers of virus-induced stomach cancers

May 17, 2018

Combination of erectile dysfunction drugs and flu vaccine may help kill remaining cancer after surgery

Jan 19, 2018

Scientists create method to sensitize triple-negative breast cancer to common immunotherapy

Jan 04, 2018

Study shows virus-boosted immunotherapy can be effective against aggressive breast cancer

Oct 11, 2017

Ontario start-up makes major deal to develop cancer-fighting viruses

Jul 11, 2017

How OICR is helping to boost the body’s ability to fight cancer

May 25, 2017

OICR launches five all-star teams of Ontario scientists to tackle some of the deadliest forms of cancer

May 25, 2017

OICR launches five large-scale Ontario research initiatives to combat some of the most deadly cancers

Feb 15, 2017

BioCanRX makes a major investment in Canadian biotherapeutics research

Nov 02, 2016

FACIT start-up Turnstone Biologics closes USD $41M financing

May 25, 2016

OICR partners with Israeli university to create new cancer genomics and immunity program

Jan 28, 2016

Trillium Therapeutics Acquires Fluorinov Pharma

Jan 05, 2016

OICR funds world-first clinical trial using cancer-fighting viruses

Jul 10, 2015

Cancer patients treated in world-first clinical trial of Canadian viral therapy